|
ZNF397 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.468400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.594200E-02 |
| Normal-vs-Stage2 |
2.577800E-01 |
| Normal-vs-Stage3 |
1.241120E-03 |
| Normal-vs-Stage4 |
5.897700E-03 |
| Stage1-vs-Stage2 |
7.359400E-01 |
| Stage1-vs-Stage3 |
1.138440E-01 |
| Stage1-vs-Stage4 |
1.938190E-01 |
| Stage2-vs-Stage3 |
1.159190E-01 |
| Stage2-vs-Stage4 |
1.638570E-01 |
| Stage3-vs-Stage4 |
7.608800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.100770E-01 |
| Normal-vs-AfricanAmerican |
1.805610E-02 |
| Normal-vs-Asian |
6.998700E-04 |
| Caucasian-vs-AfricanAmerican |
1.512620E-01 |
| Caucasian-vs-Asian |
1.206270E-04 |
| AfricanAmerican-vs-Asian |
1.423420E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.196040E-02 |
| Normal-vs-Female |
5.637800E-01 |
| Male-vs-Female |
7.701500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.253600E-02 |
| Normal-vs-Extreme_Weight |
1.746330E-02 |
| Normal-vs-Obese |
1.491220E-01 |
| Normal-vs-Extreme_Obese |
3.971400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.651200E-01 |
| Normal_Weight-vs-Obese |
7.241600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.416800E-01 |
| Extreme_Weight-vs-Obese |
3.605200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.830600E-01 |
| Obese-vs-Extreme_Obese |
8.731600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.713550E-02 |
| Normal-vs-Age(41-60Yrs) |
3.694000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.401510E-02 |
| Normal-vs-Age(81-100Yrs) |
9.383800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.275900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.313400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.839600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.032800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.364630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.341200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.317900E-02 |
| Normal-VS-Type2 PRCC |
1.163120E-03 |
| Normal-VS-KIRP CIMP |
2.976800E-04 |
| Normal-VS-Unclassified PRCC |
7.820600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.074280E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.494300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.257600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.240000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.580000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.023500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.399600E-04 |
| Normal-vs-N1 |
8.199200E-03 |
| Normal-vs-N2 |
5.960500E-03 |
| N0-vs-N1 |
9.872600E-01 |
| N0-vs-N2 |
1.948190E-01 |
| N1-vs-N2 |
3.220800E-01 |
|
|
